Scottish Development International
Scottish Development International (SDI) is part of Scotland’s main enterprise, innovation and investment agency and works to help international companies find partners in Scotland and Scottish companies develop their business overseas. SDI also works to attract inward investment and knowledge to Scotland in order to help the economy grow.
SDI has a network of offices around the world and provides a wide range of support services covering each phase of international activity, including: business mentoring, market intelligence, business location information and investor aftercare.
The Scottish Life Sciences sector counts more than 700 organisations and 35,000 people with particular strengths in supporting drug discovery and development, regenerative medicine/stem cells, animal health, medical devices, digital health and clinical translational medicine.
To find out more, visit www.sdi.co.uk and www.lifesciencesscotland.com
Katharina KraehahnSnr. Business Development Executive
Sofia NorasSenior Trade Specialist,
Shield Therapeutics plc
A de-risked commercial stage pharmaceutical company with a focus on addressing iron deficiency via its lead product Ferric Maltol, marketed in the EU as Feraccru® and approved in the US and will be marketed as Accrufer®.
David ChildsDirector of Product Supply & Commercial Alliances
Founded in 2010, Sphere Fluidics is an established Life Sciences company, originally spun out from the University of Cambridge. We initially developed 25 patented products – biochips and specialist chemicals – which currently assist hundreds of customers globally with their research.
We initially focused on producing novel biochip systems and providing R&D services. We have since extended our expertise and are developing a technology platform that enables discovery in a range of growing markets through single cell analysis. Our systems make the development of new biopharmaceuticals faster and more cost-effective, improve monoclonal antibody screening, cell line development, and overall research efficiency in a number of other applications including synthetic biology, single cell diagnostics, prognostics and single cell genome editing.
The Cyto-Mine® Single Cell Analysis System is our flagship product – the first integrated, benchtop system to automatically analyse, sort and dispense millions of individual cells in just a single day.
SQN Clinical – the biometrics partner of choice for clinical development professionals: exhibiting at booth 9.
SQN has a well-earned international reputation as a specialist data management company who can be trusted to meet the biometrics needs of your projects, while working seamlessly with your team and chosen partners. Your focus is likely to be pharmaceutical, biotechnology or medical device development; ours is to help you get your product to market as quickly and efficiently as possible – at reasonable cost with the highest confidence that it will meet regulatory needs.
For over 20 years, we’ve been taking the stress and risk out of planning, managing, analysing and reporting clinical trials. We are the preferred, trusted partner of choice for both local and internationally-based companies; we always keep our promises. The high percentage of repeat business we enjoy is testament to every member of our team going the extra mile, providing a quality service within agreed timelines and budgets, ensuring complete satisfaction.